A study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a “last resort” antibiotic for patients who have developed multi-drug resistant infections.A study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a “last resort” antibiotic for patients who have developed multi-drug resistant infections.Read More